|
Issue dtd. 1st to 15th September 2005
INSIDE
COVER STORY
INTERVIEW
TELEMEDICINE
EVENTS
PLANNING
MANAGEMENT
CONFERENCE WATCH
ACCREDITATION
RESEARCH
PHARMA
INSIGHT
NEWS
PRODUCTS
VIEWPOINT
SUPPLEMENTS
CRITICARE
LABWATCH
HOSPIUPDATE

ARCHIVES
 SUBSCRIBE
CUSTOMER SERVICE
 CONTACT US
ADVERTISE
ABOUT US

 Network Sites

  Express Computer
  IT People
  Network Magazine
  Business Traveller
  Exp. Hotelier & Caterer
  Exp. Travel & Tourism
  Exp. Pharma Pulse
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express

Untitled Document
 

 

 -
Home > Research
Research

XIGRIS: A novel agent in severe sepsis
Xigris (drotrecogin alfa activated) was introduced in India in October 2002 by Eli Lilly, marketed aggressively as a biological agent for use in severe sepsis. Xigris is recombinant human activated Protein C that has antithrombotic, anti-inflammatory and profibrinolytic properties.
Back to Top

© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.